| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8730735 | Pancreatology | 2018 | 28 Pages |
Abstract
Heparanase mRNA in PBMC and activity in plasma are closely correlated with therapeutic responsiveness and survival time, indicating that heparanase level in blood might be a sensitive but non-specific marker to monitor patients' response to anticancer treatment and to predict survival.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Wujun Wu, Lin Zhao, Yongtian Yu, Haitian Hu, Huaiping Shi, Qian'an Jia, Lixue Du,